MedPath

Bupivacaine Hydrochloride

Bupivacaine Hydrochloride Injection

Approved
Approval ID

8c168503-9120-20ea-e053-2a95a90a8bf2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 14, 2021

Manufacturers
FDA

Areva Pharmaceuticals

DUNS: 833189835

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bupivacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59923-720
Product Classification
G
Generic Name
Bupivacaine Hydrochloride
Product Specifications
Route of AdministrationEPIDURAL, INTRACAUDAL, PERINEURAL
Effective DateJanuary 14, 2021
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
BUPIVACAINE HYDROCHLORIDE ANHYDROUSActive
Quantity: 5 mg in 1 mL
Code: AKA908P8J1
Classification: ACTIB

Bupivacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59923-718
Product Classification
G
Generic Name
Bupivacaine Hydrochloride
Product Specifications
Route of AdministrationEPIDURAL, INTRACAUDAL, PERINEURAL
Effective DateJanuary 14, 2021
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BUPIVACAINE HYDROCHLORIDE ANHYDROUSActive
Quantity: 5 mg in 1 mL
Code: AKA908P8J1
Classification: ACTIB

Bupivacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59923-717
Product Classification
G
Generic Name
Bupivacaine Hydrochloride
Product Specifications
Route of AdministrationEPIDURAL, INTRACAUDAL, PERINEURAL
Effective DateJanuary 14, 2021
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BUPIVACAINE HYDROCHLORIDE ANHYDROUSActive
Quantity: 2.5 mg in 1 mL
Code: AKA908P8J1
Classification: ACTIB

Bupivacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59923-719
Product Classification
G
Generic Name
Bupivacaine Hydrochloride
Product Specifications
Route of AdministrationEPIDURAL, INTRACAUDAL, PERINEURAL
Effective DateJanuary 14, 2021
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
BUPIVACAINE HYDROCHLORIDE ANHYDROUSActive
Quantity: 2.5 mg in 1 mL
Code: AKA908P8J1
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bupivacaine Hydrochloride - FDA Drug Approval Details